Project Grant R21NS140988

Award Date 9/20/24
Completion Date 8/31/26
Dollars Obligated $436K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Bloomington, IN 47405, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372), provides $828,335 to the University of Chicago to investigate the roles of inhibitory and disinhibitory neural circuits in the formation, stabilization, and competition of neural assemblies in the cortex. The project aims to experimentally test theoretical...
This federal Project Grant award of $290,688 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award will fund research at Brandeis University to investigate the role of neuronal primary ciliary signaling in regulating the balance of excitation and inhibition in the neocortex. The research will focus on somatostatin receptor 3 (SSTR3) signaling in...
This Project Grant award, valued at $481,250.00 and provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to develop a synthetic biological system to manipulate subcellular RNAs and proteins in growth cones or synapses of subtype- and context-specific neurons. The goal is to enable unique forms of subcellular functional investigation in subtype- and...
This federal Project Grant award of $211,875.00, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to characterize the development and function of medulla visual projection (MEVP) neurons in the Drosophila visual system. The research aims to determine which neuroblasts give rise to MEVP neurons, analyze their gene expression profiles, and...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is supporting research to investigate the contributions and impact of neutrophil activity in a comorbid model of Alzheimer's disease (AD) and vascular contributions to cognitive impairment and dementia (VCID). The key objectives are to examine the neutrophil response to AD, VCID, and...
This Project Grant award of $427,625 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to develop tools for studying proteome plasticity in brain endothelial cells. The goal is to elucidate the mechanisms by which changes in neuronal energy demands lead to reprogramming of signaling pathways that control brain blood flow, which is critical for...
The National Institute of Mental Health (NIMH) awarded a $1,380,070 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Duke University to explore the cellular properties and circuit functional roles of human cortical interneurons. This research aims to generate a multimodal phenotypic catalog of human interneurons and characterize their functional organization in neural circuits. The project will utilize live brain specimens collected from neurosurgical procedures and a novel genetic...
This federal Project Grant award, ID R35NS137247, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award totaling $1,174,913.00 supports research to understand the fundamental mechanisms of homeostatic plasticity, a compensatory process that stabilizes neural function, and its potential links to neurodevelopmental disorders such as autism and...
This federal Project Grant award, issued by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $4,693,249 to the University of California, Los Angeles (UCLA) to conduct research on defining the molecular spectrum of white matter vascular lesions that drive vascular cognitive impairment and dementia (VCID). The project aims to develop a better understanding of...
The Regents of the University of Michigan was awarded a $646,000 project grant from the National Institute of Neurological Disorders and Stroke (NINDS), under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372). The funding will support research to identify the neural processes within the paraventricular nucleus of the thalamus (PVT) that underlie individual variation in cue-motivated behavior. Using fluorescence-based...

The federal Project Grant award R21NS140988, totaling $435,875.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This award, with a performance period from Sep 20, 2024 to Aug 31, 2026, will support research by the Trustees of Indiana University (the Awardee) to reveal the functional complexity of cortical vasoactive intestinal polypeptide (VIP) interneurons and their role in processing salient signals like aversive stimuli and rewards within local microcircuits. The research aims to uncover the heterogeneity of spike responses generated by genetically defined dis-inhibitory VIP interneurons and their downstream effects on postsynaptic partners, which may provide insights into the pathological operation of cortical circuits linked to attention and salient signal detection deficits observed in conditions like schizophrenia, autism, and ADHD.

Generated 7/1/25, 5:26 AM